132 related articles for article (PubMed ID: 22175303)
41. Generalized lentigines associated with familial gastrointestinal stromal tumors dramatically improved by imatinib treatment.
Hasegawa M; Shimizu A; Ieta K; Shibusawa K; Ishikawa O; Ishida-Yamamoto A; Tamura A
J Dermatol; 2020 Jun; 47(6):e241-e242. PubMed ID: 32220019
[No Abstract] [Full Text] [Related]
42. Melanotic freckle as a precursor of malignant melanoma. Report of a case.
AUSTIN WE
Can J Surg; 1963 Jul; 6():363-6. PubMed ID: 13965590
[No Abstract] [Full Text] [Related]
43. Melanotic freckle, lentigo maligna.
COSTELLO MJ; FISHER SB; DEFEO CP
Arch Dermatol; 1959 Dec; 80():753-71. PubMed ID: 13812250
[No Abstract] [Full Text] [Related]
44. Amelanotic lentigo maligna melanoma.
Abeldaño AM; Saadi ME; Brea P; Kien MC; Chouela E
Skinmed; 2004; 3(1):41-4. PubMed ID: 14724412
[No Abstract] [Full Text] [Related]
45. Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs.
Agaimy A; Märkl B; Arnholdt H; Wünsch PH; Terracciano LM; Dirnhofer S; Hartmann A; Tornillo L; Bihl MP
Virchows Arch; 2009 Aug; 455(2):101-8. PubMed ID: 19572146
[TBL] [Abstract][Full Text] [Related]
46. Eyelid reconstruction with modified Tenzel flap after lentigo maligna melanoma resection.
Eisendle K; Puviani M; Pagani A; Thuile T
J Dtsch Dermatol Ges; 2020 Nov; 18(11):1338-1342. PubMed ID: 32989892
[No Abstract] [Full Text] [Related]
47. Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).
Daniels M; Lurkin I; Pauli R; Erbstösser E; Hildebrandt U; Hellwig K; Zschille U; Lüders P; Krüger G; Knolle J; Stengel B; Prall F; Hertel K; Lobeck H; Popp B; Theissig F; Wünsch P; Zwarthoff E; Agaimy A; Schneider-Stock R
Cancer Lett; 2011 Dec; 312(1):43-54. PubMed ID: 21906875
[TBL] [Abstract][Full Text] [Related]
48. Collision of malignant melanoma (lentigo maligna type) with squamous cell carcinoma in solar-damaged skin of the face.
Ahlgrimm-Siess V; Hofmann-Wellenhof R; Zalaudek I; Cerroni L; Kerl H
Dermatol Surg; 2007 Jan; 33(1):122-4. PubMed ID: 17214694
[No Abstract] [Full Text] [Related]
49. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
Woodmansee CS; McCall MW
Dermatol Surg; 2009 Aug; 35(8):1286-9. PubMed ID: 19438661
[No Abstract] [Full Text] [Related]
50. [Lentigo maligna and lentigo maligna melanoma of the cheeks. Analysis of different growth patterns via photographic records].
Stuiber T; Paul E
Hautarzt; 2001 Oct; 52(10):873-7. PubMed ID: 17690816
[TBL] [Abstract][Full Text] [Related]
51. Lentigo maligna melanoma and excisional biopsy techniques.
Meffert JJ; Albertini JG
Am Fam Physician; 1999 Mar; 59(5):1108, 1113, 1116. PubMed ID: 10088870
[No Abstract] [Full Text] [Related]
52. Simultaneous occurrence of multiple melanoma in situ on sun-damaged skin (lentigo maligna), solar lentigo and labial melanosis: the value of dermoscopy in diagnosis.
Massi D; Nardini P; De Giorgi V; Carli P
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):193-7. PubMed ID: 10642055
[TBL] [Abstract][Full Text] [Related]
53. Amelanotic lentigo maligna.
Sanz de Galdeano C; Manrique P; Alvarez JA; Gonzalez MR; Calderón MJ; Zabala R; Garciandia C
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):83-5. PubMed ID: 9731976
[No Abstract] [Full Text] [Related]
54. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
[TBL] [Abstract][Full Text] [Related]
55. Clinical pathology case conference. Lentigo maligna melanoma.
Blanchaert RH; Ord RA
MSDA J; 1997 SPRING; 40(2):53-4. PubMed ID: 9571929
[No Abstract] [Full Text] [Related]
56. Multiloculated lentigo maligna melanoma in a patient without evidence for xeroderma pigmentosum.
Brandt O; Abeck D; Weichenthal M; Steinkraus V; Breitbart E; Jung EG; Ring J
Acta Derm Venereol; 1995 Jul; 75(4):326-7. PubMed ID: 8578964
[No Abstract] [Full Text] [Related]
57. [Rotation advancement flap with subcutaneous pedicle in the jugal region following excision of lentigo maligna melanoma].
Dugourd PM; Cogrel O
Ann Dermatol Venereol; 2020 Oct; 147(10):693-695. PubMed ID: 32680709
[No Abstract] [Full Text] [Related]
58. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological characteristics of 270 patients with lentigo maligna and lentigo maligna melanoma: data from a German skin cancer centre.
Gambichler T; Kempka J; Kampilafkos P; Bechara FG; Altmeyer P; Stücker M
Br J Dermatol; 2014 Dec; 171(6):1605-7. PubMed ID: 24958545
[No Abstract] [Full Text] [Related]
60. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections.
Stonecipher MR; Leshin B; Patrick J; White WL
J Am Acad Dermatol; 1993 Oct; 29(4):589-94. PubMed ID: 8408795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
